Success Stories: NAILG Helps an Indian Scientist Achieve NIW Approval for Tackling Medication Safety Challenges
Client’s Testimonial:
“I am very grateful for your assistance throughout this process.”
On January 29th, 2025, we received another EB-2 NIW (National Interest Waiver) approval for a Scientist-I in the Field of Medicinal Chemistry (Approval Notice).
General Field: Medicinal Chemistry
Position at the Time of Filing: Scientist-I
Country of Origin: India
State of Residence at the Time of Filing: Wisconsin
Approval Notice Date: January 29th, 2025
Processing Time: 3 months, 4 days (Premium Processing Requested)
Case Summary:
Every year, millions of patients suffer from preventable harm caused by unsafe or ineffective medications. Our client, a medicinal chemistry expert, has dedicated his career to solving this problem. His research into drug design and optimization has now been recognized by USCIS with the approval of his EB-2 NIW (National Interest Waiver) petition, prepared by North America Immigration Law Group (NAILG).
Research with Substantial Merit and National Importance: After carefully reviewing his credentials, NAILG recognized him as a strong candidate for the NIW category. His proposed endeavor, to investigate the design, synthesis, optimization, and characterization of small molecule compounds, addresses urgent national healthcare challenges. With drug-resistant infections causing tens of thousands of deaths annually in the U.S. and costing billions in treatment expenses, his work directly supports national efforts to enhance drug safety, reduce healthcare costs, and sustain America’s leadership in pharmaceutical innovation.
Well Positioned to Advance the Proposed Endeavor: Our client’s strong academic and professional background, including a Ph.D. in chemical sciences and research appointments at internationally recognized institutions, has prepared him to carry forward this vital work. He has published extensively, with 22 peer-reviewed journal articles, 2 abstracts, 1 granted patent, and 2 patent applications, demonstrating his ability to produce original and impactful research. His publications have been cited 547 times, placing several of his papers among the most highly cited for their publication years.
Beyond authorship, he has also been invited to serve the academic community as a peer reviewer, completing at least 24 reviews for high-profile journals. He has further demonstrated leadership as a guest editor for a special issue on PET imaging, underscoring his recognition as a respected authority in his field.
Due to its clear national importance, our client’s research has been supported with funding from the U.S. Congressionally Directed Medical Research Programs and the National Institute of Allergy and Infectious Diseases.
NIW Approval and Outlook: Based on his impressive record of original research, sustained international recognition, and proven capacity to advance drug discovery, USCIS approved his NIW petition. One expert summarized the importance of his contributions:
"To conclude, [Client] has advanced the field of medicinal chemistry by applying his extensive knowledge of pharmacophores and prodrugs to improve the safety and efficacy of therapeutic agents and drug development processes. [Client]’s prowess in medicinal chemistry situates him as a leader in the field and establishes his inherent value to the United States."
With the guidance of the North America Immigration Law Group (NAILG), he has secured approval to continue his critical research. His ongoing work in medicinal chemistry will help shape the future of therapeutic development, strengthening America’s ability to address global health challenges through innovation.